Hydroxychloroquine Effects on TLR Signalling: Underexposed but Unneglectable in COVID-19

The main basis for hydroxychloroquine (HCQ) treatment in COVID-19 is the compound's ability to inhibit viral replication in vitro. HCQ also suppresses immunity, mainly by interference in TLR signalling, but reliable clinical data on the extent and nature of HCQ-induced immunosuppression are lac...

Descripción completa

Detalles Bibliográficos
Autores principales: in ‘t Veld, Aliede E., Jansen, Manon A. A., Ciere, Luuk C. A., Moerland, Matthijs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949870/
https://www.ncbi.nlm.nih.gov/pubmed/33763494
http://dx.doi.org/10.1155/2021/6659410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949870/
https://www.ncbi.nlm.nih.gov/pubmed/33763494
http://dx.doi.org/10.1155/2021/6659410

Ejemplares similares